Log in or Sign up for Free to view tailored content for your specialty!
Hepatology News
Do not outlive your money: What inflation rate to use for your retirement projections
Most investors, when considering their financial future, have a common number one concern – that they will not have saved enough to sustain them in retirement. In other words, they fear that they will outlive their money.
‘We’re not waiting’: World Hepatitis Day pushes for urgent elimination of viral hepatitis
On Friday, clinicians and researchers across the world recognized World Hepatitis Day as an opportunity to honor the “more than a million lives lost to hepatitis” every year and redouble national efforts to stop its spread.
Log in or Sign up for Free to view tailored content for your specialty!
Higher animal protein intake increases mortality risk in cirrhosis by nearly fourfold
Higher intake of total and dairy protein and lower animal protein consumption correlated with a reduced risk for mortality among patients with cirrhosis, according to data published in BMC Gastroenterology.
NAFLD familial risk bests FIB-4 in identifying advanced fibrosis in first-degree relatives
A familial risk score comprised of age, obesity, type 2 diabetes and family history of nonalcoholic fatty liver disease accurately identified advanced fibrosis among first-degree relatives, according to researchers.
Q&A: ‘Normalization’ of biochemical markers in PBC may be possible with seladelpar
After 3 months of treatment, seladelpar significantly improved pruritus and markers of liver injury compared with placebo in patients with primary biliary cholangitis, CymaBay Therapeutics recently announced.
Despite narrowing the gap, racial disparities persist in liver transplantation, mortality
Disparities in receipt of liver transplantation and mortality persisted over time among hospitalized Black and Hispanic patients with decompensated cirrhosis compared with their white counterparts, according to data in JAMA Network Open.
Type 2 diabetes heightens risk for hepatic decompensation, HCC in patients with NAFLD
Type 2 diabetes was an independent predictor of hepatic decompensation and development of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease, according to data.
One-fifth of NASH patients develop cirrhosis in 4 years; lower risk for women, nonsmokers
Among patients with nonalcoholic steatohepatitis in the United States, 20% progressed to cirrhosis within 4 years, with female sex and nonsmoking status linked to lower risk for progression, according to data from the TARGET-NASH trial.
BLOG: Indemnification — Who is on the hook for the liabilities of the practice?
You’ve made the decision to sell your practice, got your house in order and hired advisers. Now you need to start making decisions regarding the terms of the sale.
Bulevirtide induces a virologic, biochemical response in chronic hepatitis D
Bulevirtide was safe and increased the proportion of patients with undetectable hepatitis D virus RNA among those in both the 2 mg and 10 mg dosage groups, according to data published in The New England Journal of Medicine.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read